AVNS earnings

Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidanceDelivered full-year organic growth of 6% in strategic segmentsExpanded transformation initiatives expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026ALPHARETTA, Ga., Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported fourth quarter and full-year 2025 results. "I'm very pleased with our fourth quarter and full-year results, which demonstrate meaningful progress on our strategic priorities," said David Pacitti, Avanos' chief

ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2025 on Tues., Feb. 24 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer.To instantly join the conference call by phone, use the following link to register close to the cal

Delivered double-digit growth in Specialty Nutrition Systems segmentClosed acquisition of Nexus Medical, providing a complementary technology for the Specialty Nutrition Systems segmentRaising and narrowing top-line guidance and adjusted EPS guidance for the full yearALPHARETTA, Ga., Nov. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2025 financial results. "I am pleased with our third quarter results, both operationally and commercially," said David Pacitti, Avanos' chief executive officer. Pacitti continued, "Avanos delivered double-di

ALPHARETTA, Ga., Oct. 27, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2025 on Wed., Nov. 5, at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, and Scott Galovan, senior vice president and chief financial officer. To instantly join the conference call by phone, use the following link to register close to the call start time:

ALPHARETTA, Ga., Aug. 5, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported second quarter 2025 financial results. "Building off our first quarter results, we delivered a strong second quarter anchored by continued healthy performance in our life-sustaining Specialty Nutrition Systems segment along with continued progress in our opioid-sparing Pain Management & Recovery segment," said David Pacitti, Avanos' chief executive officer. Pacitti continued, "Our overall execution this quarter was solid, and the steady progress we've made against each of our transfor

ALPHARETTA, Ga., May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported first quarter 2025 financial results. "In my first couple of weeks at Avanos, I've noticed that the transformation efforts made around the portfolio, the organizational structure and cost management have positioned us well to accelerate our growth profile," said David Pacitti, Avanos's recently appointed Chief Executive Officer. Pacitti continued, "I really like the energy and strategic focus we have right now, which can be leveraged for more consistent execution, to identify more go-t

ALPHARETTA, Ga., April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Dave Pacitti, chief executive officer, Jason Pickett, interim chief financial officer, Scott Galovan, senior vice president, strategy and corporate development, and Gary Blackford, Avanos board chairman. To instantly jo

ALPHARETTA, Ga., Feb. 26, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported fourth quarter and full-year 2024 results. "We are pleased with our fourth quarter results, which delivered 5% organic growth and continued execution on each of our transformation initiative priorities," said Michael Greiner, Avanos's interim chief executive officer. Greiner continued, "For the full year, we generated $83 million of free cash flow and $108 million of adjusted EBITDA. We currently have net debt of approximately $20 million. We believe our strong financial position wil

ALPHARETTA, Ga., Feb. 19, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2024 on Wednesday, Feb. 26 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Michael Greiner, interim chief executive officer and Scott Galovan, senior vice president, strategy and corporate development. To instantly join the conference call by phone, use the following link to

ALPHARETTA, Ga., Oct. 30, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2024 financial results and announced the retirement of its CEO, Joe Woody. Gary Blackford, Avanos Board Chairman, noted, "Joe has decided to retire after leading Avanos for the past seven years. Joe has agreed to assist the Company in the transition of leadership, and will continue to consult with the Company through April of next year. Avanos is better positioned financially and organizationally today to achieve its longer-term value creation goals because of Joe's lea

ALPHARETTA, Ga., Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer. To join the live conference call, dial 1-800-836-8184 in the United States. A

ALPHARETTA, Ga., July 31, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported second quarter 2024 financial results. "We are pleased with our second quarter results and the cumulative progress we have made at the mid-year point," said Joe Woody, Avanos's chief executive officer. Woody continued, "Digestive Health continues to lead in delivering high-single digit growth while Pain Management and Recovery performance is improving with quarter-over-quarter sequential growth, and we are seeing meaningful progress on our other transformation objectives, all of whic

ALPHARETTA, Ga., July 24, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2024 on Wednesday, July 31 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer. To join the live conference call, dial 1-800-836-8184 in the United States.

ALPHARETTA, Ga., May 2, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported first quarter 2024 financial results. "As we begin the second year of our three-year transformation initiative, we are pleased with our first quarter results," said Joe Woody, Avanos's chief executive officer. Woody added, "We continue to make progress on our long-term margin expansion targets, are delivering on our Digestive Health growth objectives and have made improvements in our Pain Management and Recovery franchise that will support our mid-single digit growth in the back half o

ALPHARETTA, Ga., April 25, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer. To join the live conference call, dial 1-800-836-8184 in the United States. A s

ALPHARETTA, Ga., Feb. 20, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported fourth quarter and full-year 2023 results. "We were very pleased with the overall execution on our transformation initiative last year, which sets the foundation for more profitable growth in 2024 and for reaching our mid-term financial targets in 2025," said Joe Woody, Avanos's chief executive officer. Woody continued, "We believe we are poised to maintain the positive momentum in our Digestive Health portfolio and we are also confident that our strategy for the Pain Management and

ALPHARETTA, Ga., Feb. 13, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2023 on Tuesday, Feb. 20 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcas

ALPHARETTA, Ga., Jan. 4, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported selected, unaudited preliminary financial results for the fourth quarter and full-year ended December 31, 2023 and revised its preliminary revenue outlook for 2024. Preliminary Unaudited Financial Results For the fourth quarter ended December 31, 2023, Avanos Medical, Inc. (the "Company") expects net sales in the range of $170 million to $173 million, a decrease of approximately 6.5% to 4.5% compared to the same period in 2022, with net sales for the year ended December 31, 2023 anti

ALPHARETTA, Ga., Aug. 9, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported second quarter 2023 financial results. "We posted solid second quarter earnings, with Digestive Health continuing to deliver above-market growth and expanded margins," stated Joe Woody, Avanos's chief executive officer. Woody continued, "Separately, we continue to deliver on our transformation priorities and remain highly focused on implementing our new pain franchise strategy outlined at our Investor Day." Second Quarter 2023 Financial Highlights Total net sales from continuing opera

ALPHARETTA, Ga., Aug. 2, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2023 on Wednesday, Aug. 9 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer. To join the live conference call, dial 877-240-5772 in the United States. A si

ALPHARETTA, Ga., May 3, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported first quarter 2023 financial results. "Our first quarter results were mixed, with our digestive health portfolio continuing to outperform, strong adjusted earnings per share and continued margin improvement partially offset by our results in our pain portfolio," stated Joe Woody, Avanos's chief executive officer. Woody continued, "Separately, we made considerable progress on our transformation initiative during the first quarter. We look forward to sharing further details about these i

ALPHARETTA, Ga., April 26, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2023 on Wednesday, May 3 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president, chief financial officer, and chief transformation officer. To join the live conference call, dial 877-240-5772 in the United States. A si

ALPHARETTA, Ga., Feb. 21, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported fourth quarter and full-year 2022 results. "We were pleased to finish 2022 with a strong fourth quarter, continued margin expansion and meaningful free cash flow," stated Joe Woody, Avanos' chief executive officer. Woody continued, "Our team is focused on execution and we are determined to deliver on the three-year transformation plan we described last month at the JPMorgan conference." 2022 Financial Highlights Fourth quarter net sales totaled $217 million, a 12% increase from the p

ALPHARETTA, Ga., Feb. 14, 2023 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2022 on Tuesday, Feb. 21 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcas

ALPHARETTA, Ga., Nov. 2, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2022 financial results. "We are very pleased with our third quarter performance despite continuing headwinds associated with supply chain disruptions and other macro-economic factors," said Joe Woody, Avanos' Chief Executive Officer. Woody continued, "We again delivered strong margin and free cash flow results building on our second quarter performance and anticipate further improvement in most of our financial metrics in the fourth quarter." Third Quarter 2022 Financial

ALPHARETTA, Ga., Oct. 26, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2022 on Wednesday, Nov. 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcast of the call

ALPHARETTA, Ga., Aug. 9, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported second quarter 2022 financial results. "Despite ongoing raw material availability and associated supply chain disruptions, underlying demand for our products remains strong," said Joe Woody, Avanos' Chief Executive Officer. Woody continued, "We delivered on expansion of our gross and operating margin, and generated meaningful free cash flow in a tough environment inclusive of inflationary and foreign currency headwinds. We anticipate strong results for the full year despite continued

ALPHARETTA, Ga., July 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2022 on Tuesday, August 9 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcast of the call

ALPHARETTA, Ga., May 4, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported first quarter 2022 financial results. "Coming off last year's solid finish, we maintained our momentum through the first quarter while adding OrthogenRx to our portfolio," stated Joe Woody, Avanos' chief executive officer. Woody continued, "I am very pleased with our first quarter results despite persistent global economic headwinds. We met our customers' orders and meaningfully improved our gross margins in the face of inflationary pressures and a difficult supply chain environment, a

ALPHARETTA, Ga., April 27, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Wednesday, May 4 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcast of the call

ALPHARETTA, Ga., Feb. 23, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported fourth quarter and full-year 2021 results. "We are happy with our top line performance despite the extended duration of the COVID-19 pandemic and related supply chain headwinds," stated Joe Woody, Avanos' chief executive officer. Woody continued, "Our employees remain focused on advancing our strategy despite the challenges, and we are very pleased with our execution throughout the year including growing the organic business by 4 percent, maintaining cost discipline across our operat

ALPHARETTA, Ga., Feb. 15, 2022 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2021 on Wednesday, Feb. 23 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webc

ALPHARETTA, Ga., Nov. 2, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported third quarter 2021 financial results. "We continue to see unevenness in the recovery across our product portfolio but are very pleased with our overall execution. While there were headwinds in acute pain resulting from continued delays and postponements of elective surgical procedures, we met or exceeded all of our other priorities and made meaningful progress in improving our gross profit margins through the third quarter" stated Joe Woody, Avanos' chief executive officer. Woody con

ALPHARETTA, Ga., Oct. 26, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2021 on Tuesday, Nov. 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcast of the call an

ALPHARETTA, Ga., Aug. 3, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) today reported second quarter 2021 financial results. "Through the first-half of the year our commercial teams continue to execute well and build sales momentum across our franchises while maintaining spending discipline," stated Joe Woody, Avanos' chief executive officer. "During the quarter we saw sequential net sales increase across our Pain Management franchise from the return of elective procedures and execution of our growth initiatives, highlighted by our COOLIEF and Game Ready therapies whic

ALPHARETTA, Ga., July 27, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE:AVNS) will webcast its conference call discussing financial results and business highlights for the second quarter 2021 on Tuesday, August 3 at 9 a.m. ET. The company will issue a news release detailing its results before the market opens that same day. The conference call will be hosted by Joe Woody, chief executive officer, and Michael Greiner, senior vice president and chief financial officer. To join the live conference call, dial 877-240-5772 in the United States. A simultaneous webcast of the call